Mounjaro Side Effects: What to Know About Stomach Pain

Stomach pain, nausea and digestive discomfort are recognised side effects of tirzepatide, most pronounced when starting or after each dose step up.
Severe, persistent stomach pain radiating to the back (with or without vomiting) requires urgent medical assessment, as the MHRA has flagged acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines.
Most mild-to-moderate GI symptoms can be eased by eating smaller portions, avoiding high-fat meals and staying well hydrated.
Any suspected side effect can be reported to the MHRA via the Yellow Card scheme.

Stomach pain is one of the most commonly reported side effects of Mounjaro (tirzepatide). It tends to appear after starting treatment or after a dose increase, usually settles within a few days to two weeks, and is linked to how tirzepatide slows digestion. That said, not all stomach pain during Mounjaro treatment is routine — some patterns need prompt medical attention. This page explains the difference, drawing on NHS guidance on tirzepatide and MHRA safety communications. Mounjaro is a prescription-only medicine; a prescriber assesses whether it is clinically suitable for you before it is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to tell routine stomach pain from something that needs medical help

Why does Mounjaro cause stomach pain in the first place?

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) which together slow the rate at which the stomach empties. Food sits in the stomach longer, and that slower transit time is part of why appetite falls. It is also, frankly, why many people feel discomfort. When digestion slows, gas builds, the gut wall stretches, and the result can be cramping, bloating, or a dull ache in the upper abdomen.

The timing is fairly predictable. Symptoms are most likely in the 24 to 48 hours after an injection, and they tend to be sharpest in the first weeks at any given dose. For most people they ease considerably once the body adjusts. The full side-effect picture with Mounjaro goes beyond the stomach, but GI effects are reliably the most common category across the clinical trial programme.

If your pain sits alongside nausea, loose stools or excessive burping, that is a well-documented pattern. There is more detail on the digestive cluster specifically at Mounjaro, stomach pain and diarrhoea.

What does 'normal' stomach discomfort look like on tirzepatide?

Mild-to-moderate cramping or aching that comes on within a day or two of your injection, improves on its own within a week, and does not stop you going about your day is typical for the early weeks of treatment. It usually sits in the upper-middle abdomen, sometimes alongside nausea or a feeling of fullness that arrives quickly at meals.

Several practical adjustments help. Smaller portions at each meal reduce the gastric load. High-fat or very rich food reliably worsens GI symptoms on tirzepatide. Eating slowly and avoiding lying down immediately after a meal also makes a difference. Keeping fluid intake up matters too — persistent nausea can quietly lead to dehydration if you are not drinking enough.

If discomfort is concentrated lower in the gut, with cramping and loose stools, the combination is common enough that it is worth reading about stomach cramps and diarrhoea on Mounjaro separately. Sulphur burping alongside pain is another documented pattern, covered at sulphur burps and stomach pain on Mounjaro.

When should stomach pain on Mounjaro send you to get medical help?

This is the part that matters most. On 29 January 2026 the MHRA issued a Drug Safety Update for GLP-1 receptor agonist medicines, identifying acute pancreatitis as a known (though infrequent) serious risk. The warning sign is severe stomach pain that does not ease, often radiating through to the back, and which may or may not be accompanied by vomiting. If that description fits what you are experiencing, stop waiting for it to pass and seek urgent medical care.

Other patterns that warrant prompt attention: pain that is getting progressively worse rather than settling, pain severe enough to affect your breathing or posture, or any combination of intense abdominal pain with fever, jaundice (yellowing of the skin or eyes), or very dark urine, which can indicate a gallbladder problem. Gallstone-related issues are a recognised risk with GLP-1 medicines, given the rate of weight loss.

The NHS patient page for tirzepatide on nhs.uk lists the symptoms that need urgent review. If you are unsure whether your pain falls into the concerning category, contact your prescriber, call 111, or go to your nearest urgent treatment centre. Do not try to manage ambiguous or escalating pain at home by reducing your dose.

Back pain sometimes appears alongside abdominal discomfort on tirzepatide, if that applies to you, is back pain a side effect of Mounjaro covers the evidence on that question directly.

What can you do to reduce stomach pain while on Mounjaro?

If you know a dose increase is coming, the most useful thing is to plan your meals around it. The 48 hours post-injection are the window where symptoms peak, so keeping food lighter and lower in fat during that period reduces the trigger load. Alcohol amplifies gastric irritation and is worth cutting back during the adjustment weeks.

Staying hydrated is not a cliché here, it is genuinely protective. Persistent nausea makes people drink less, which concentrates digestive acids and makes pain worse. Small, regular sips of water throughout the day work better than large glasses when your stomach is unsettled.

If symptoms are significant and not settling, your prescriber can review your pace of dose escalation. Titration is not a race, spending longer at a lower dose before stepping up is a legitimate clinical choice, not a failure. That conversation starts with the people looking after your treatment.

If you are considering starting treatment, our prescribers discuss side effects including stomach pain as part of every consultation. You can start your free consultation and get a same-day clinical review from a GPhC-registered prescriber. For a broader view of what Mounjaro treatment involves, the Mounjaro overview is a good starting point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions